2025

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.
Korenkov, M. ORCID: https://orcid.org/0000-0002-2988-8483, Liebaert, J. ORCID: https://orcid.org/0000-0002-2988-8483, Yousefian, S. ORCID: https://orcid.org/0000-0003-0902-0369, Schwartz, S. ORCID: https://orcid.org/0000-0001-8833-5793, Demel, U.M. ORCID: https://orcid.org/0000-0002-6480-4185, Braune, J. ORCID: https://orcid.org/0000-0003-2026-2641, Odabasi, M.C., Herzberg, L., Böckle, D., Görür, N.C. ORCID: https://orcid.org/0000-0001-7857-2461, V. Landenberg-Roberg, V., Bohl, S., Tregel, E., Hennig, S., Franke, C. ORCID: https://orcid.org/0000-0002-5609-2472, Haas, S. ORCID: https://orcid.org/0000-0001-9227-2051, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Krönke, J. and Busse, A. ORCID: https://orcid.org/0000-0002-3470-6947
Blood Cancer Journal 15 (1): 168. 20 October 2025

2024

Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.
Gross, S., Ihlow, J. ORCID: https://orcid.org/0000-0001-5484-1321, Busack, L., Adamiak, K., Schrezenmeier, J., Jesse, J., Schwarz, M., Flörcken, A., Vuong, L.G., Rieger, K., Krönke, J. ORCID: https://orcid.org/0000-0002-4649-0506, le Coutre, P., Boldt, V., von Brünneck, A.C., Horst, D., Burmeister, T. ORCID: https://orcid.org/0000-0003-4843-2876, Blau, I.W., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510 and Westermann, J.
Blood Cancer Journal 14 (1): 160. 16 September 2024

2023

The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas.
Kouroukli, A.G., Fischer, A. ORCID: https://orcid.org/0000-0002-7145-2544, Kretzmer, H., Chteinberg, E., Rajaram, N., Glaser, S., Kolarova, J., Bashtrykov, P., Mathas, S. ORCID: https://orcid.org/0000-0001-9626-1413, Drexler, H.G., Ohno, H., Ammerpohl, O., Jeltsch, A. ORCID: https://orcid.org/0000-0001-6113-9290, Siebert, R. and Bens, S. ORCID: https://orcid.org/0009-0008-5263-495X
Blood Cancer Journal 13 (1): 98. 26 June 2023

2016

MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia.
Krowiorz, K., Ruschmann, J., Lai, C., Ngom, M., Maetzig, T., Martins, V., Scheffold, A., Schneider, E., Pochert, N., Miller, C., Palmqvist, L., Staffas, A., Mulaw, M., Bohl, S.R., Buske, C., Heuser, M., Kraus, J., O'Neill, K., Hansen, C.L., Petriv, O.I., Kestler, H., Döhner, H., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Döhner, K., Humphries, R.K., Rouhi, A. and Kuchenbauer, F.
Blood Cancer Journal 6 (12): e508. December 2016

2014

Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model.
Schwarzer, R., Nickel, N., Godau, J., Willie, B.M., Duda, G.N., Schwarzer, R., Cirovic, B. ORCID: https://orcid.org/0000-0002-0754-0099, Leutz, A. ORCID: https://orcid.org/0000-0001-8259-927X, Manz, R., Bogen, B., Dörken, B. ORCID: https://orcid.org/0000-0001-7991-3643 and Jundt, F.
Blood Cancer Journal 4 : e217. 13 June 2014